(Q44732240)

5 December 2017

title

The efficacy of voriconazole in 24 ocular Fusarium infections (English)

1 reference

5 December 2017

1 reference

ChEBI release 2020-05-28

7

1 reference

5 December 2017

P Troke

1

1 reference

5 December 2017

G Obenga

2

1 reference

5 December 2017

T Gaujoux

3

1 reference

5 December 2017

P Goldschmidt

4

1 reference

5 December 2017

A-L Bienvenu

5

1 reference

5 December 2017

M Cornet

6

1 reference

5 December 2017

D Pons

8

1 reference

5 December 2017

S Ranque

9

1 reference

5 December 2017

K Sitbon

10

1 reference

5 December 2017

C Chaumeil

11

1 reference

5 December 2017

V Borderie

12

1 reference

5 December 2017

O Lortholary

13

1 reference

5 December 2017

language of work or name

1 reference

21 June 2012

1 reference

5 December 2017

1 reference

5 December 2017

volume

41

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

15-20

1 reference

Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Fusarium infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Fungal keratitis in the United Kingdom 2003-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Single and multidose ocular kinetics and stability analysis of extemporaneous formulation of topical voriconazole in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Voriconazole in the treatment of fungal eye infections: a review of current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Comparison of natamycin and voriconazole for the treatment of fungal keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Topical and oral voriconazole in the treatment of fungal keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Persistent photopsia following course of oral voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

An outbreak of fusarium keratitis associated with contact lens use in the northeastern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

A case series of contact lens-associated Fusarium keratitis in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Preparation and stability of voriconazole eye drop solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Management of endogenous fungal endophthalmitis with voriconazole and caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Intracameral voriconazole: in vitro safety for human ocular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Fungal keratitis in London: microbiological and clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

High genetic diversity and poor in vitro response to antifungals of clinical strains of Fusarium oxysporum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0273-2

Fungal keratitis in France

21 January 2018

1 reference

12 December 2020

Spectrum of fungal keratitis in north China

1 reference

12 December 2020

Ocular manifestations of candidemia

1 reference

12 December 2020

Fungal keratitis at the Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts: retrospective study of 19 cases

1 reference

12 December 2020

Voriconazole versus natamycin as primary treatment in fungal corneal ulcers

1 reference

12 December 2020

Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis

1 reference

12 December 2020

Update on the treatment of disseminated fusariosis: Focus on voriconazole.

1 reference

12 December 2020

10.1007/S15010-012-0273-2

Identifiers

DOI

1 reference

5 December 2017

1 reference